A New Treatment For Parkinson's Disease Is Awaiting Final FDA Approval
Main Category: Parkinson's DiseaseArticle Date: 08 May 2007 - 12:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  |
3.52 (52 votes) |
| Healthcare Prof: |  |
3.44 (16 votes) |
| Article Opinions: | 5 posts |
Receive updates upon approval by the Food and Drug Administration about the availability of a new anti-Parkinson's medication delivered once a day.
One of the most promising new drug therapies for the treatment of Parkinson's disease is a new dopamine agonist (a drug that mimics the action of dopamine in the brain). Unlike other dopamine agonists, this new drug is is delivered via a delivery system that enables blood levels of the drug to stay consistent throughout the day. Consistent blood levels are important because blood levels that are too high can lead to side effects such as uncontrolled movements and blood levels that are too low may not adequately control the symptoms of Parkinson's disease.
Studies have suggested that this new Parkinson's therapy may have properties that not only lessen parkinsonian symptoms, but may also protect nerve cells in the substania nigra from degeneration and death.
Clinical trials have been completed for this new Parkinson's therapy and it is currently awaiting FDA approval in the United States for the treatment of the symptoms of early Parkinson's disease.
Learn More
www.myparkinsonsinfo.com
Visit our parkinson's disease section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/70093.php>
APA
http://www.medicalnewstoday.com/releases/70093.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (5)
Treatment Of PD
posted by A.C.Vajpai on 6 Oct 2007 at 12:59 amIts an excellent update on drug treatment for PD. Waiting for FDA's approval so that more information and drug can be used for betterment of the health and life-quality of affected lot.
thumbs up!
posted by fro labrador on 23 Feb 2011 at 4:59 amThat's a great news. I hope for the approval as soon as possible. My mother has a PD that's why I'm waiting for this drug to be released.
Godbless.
Its over due
posted by Robert Rice on 13 Oct 2011 at 10:29 pmThis new agonist should be available now since the
clinical trials are complete.If the decision makers
had this disease, it would already be available.
Time is not a luxury
posted by Robert Rice on 7 Feb 2012 at 2:40 amCould anyone email me on whats the name of drug
and manufacturer.and what countries are already using.always
Further information
posted by Jenny Hutchings on 7 Feb 2012 at 3:22 amThe Parkinson's drug approved in 2007 was Rotigotine (Neupro®) you can find further information on drugs available for Parkinson's here:
http://toolkit.parkinson.org/content/dopamine-agonists
http://www.neupro.com/AppStartUp/Main.asp should be able to answer your questions.
Best of luck.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
